Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
Moodys
Medtronic
Colorcon
Merck

Last Updated: October 23, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR OXYCODONE AND ASPIRIN (HALF-STRENGTH)

See Plans and Pricing

« Back to Dashboard

Clinical Trials for Oxycodone And Aspirin (half-strength)

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00771758 Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With Osteoporosis Completed Grünenthal GmbH Phase 3 2008-09-01 The purpose of this study is to determine the effectiveness and safety of tapentadol immediate release (IR) as compared with placebo and oxycodone IR in patients with acute pain caused by vertebral compression fractures (VCF) associated with assumed osteoporosis for whom treatment with oral opioid analgesics is appropriate.
NCT00771758 Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With Osteoporosis Completed Ortho-McNeil Janssen Scientific Affairs, LLC Phase 3 2008-09-01 The purpose of this study is to determine the effectiveness and safety of tapentadol immediate release (IR) as compared with placebo and oxycodone IR in patients with acute pain caused by vertebral compression fractures (VCF) associated with assumed osteoporosis for whom treatment with oral opioid analgesics is appropriate.
NCT00814580 Safety and Efficacy of Tapentadol Immediate Release (IR) and Oxycodone IR for Treatment of Acute Post-op Pain Following Elective Arthroscopic (Surgery Using a Thin Flexible Scope) Shoulder Surgery Completed Grünenthal GmbH Phase 3 2008-12-01 The purpose of this study is to evaluate how tapentadol immediate release (IR) and oxycodone IR treat moderate to severe post-operative pain after elective arthroscopic shoulder surgery.
NCT00814580 Safety and Efficacy of Tapentadol Immediate Release (IR) and Oxycodone IR for Treatment of Acute Post-op Pain Following Elective Arthroscopic (Surgery Using a Thin Flexible Scope) Shoulder Surgery Completed Ortho-McNeil Janssen Scientific Affairs, LLC Phase 3 2008-12-01 The purpose of this study is to evaluate how tapentadol immediate release (IR) and oxycodone IR treat moderate to severe post-operative pain after elective arthroscopic shoulder surgery.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Oxycodone And Aspirin (half-strength)

Condition Name

Condition Name for Oxycodone And Aspirin (half-strength)
Intervention Trials
Postoperative Pain 1
Post Operative Pain Control 1
Polycythemia Vera 1
Migraine Disorders 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Oxycodone And Aspirin (half-strength)
Intervention Trials
Pain, Postoperative 2
Back Pain 1
Polycythemia Vera 1
Acute Pain 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Oxycodone And Aspirin (half-strength)

Trials by Country

Trials by Country for Oxycodone And Aspirin (half-strength)
Location Trials
United States 23
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Oxycodone And Aspirin (half-strength)
Location Trials
New York 3
North Carolina 3
California 2
Arizona 2
Pennsylvania 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Oxycodone And Aspirin (half-strength)

Clinical Trial Phase

Clinical Trial Phase for Oxycodone And Aspirin (half-strength)
Clinical Trial Phase Trials
Phase 4 2
Phase 3 2
Phase 2 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Oxycodone And Aspirin (half-strength)
Clinical Trial Phase Trials
Completed 3
Recruiting 2
Suspended 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Oxycodone And Aspirin (half-strength)

Sponsor Name

Sponsor Name for Oxycodone And Aspirin (half-strength)
Sponsor Trials
Ortho-McNeil Janssen Scientific Affairs, LLC 2
Grünenthal GmbH 2
Albany Medical College 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Oxycodone And Aspirin (half-strength)
Sponsor Trials
Industry 6
Other 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
McKinsey
Moodys
Medtronic
Colorcon
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.